Well Purposed. The commercial case for a healthier world.

Well Purposed. The commercial case for a healthier world

The fortnightly letter on health systems, economics, and what it actually takes to build and scale in HealthTech - read by 7,500 founders, investors, and operators.

There is a meeting happening right now inside the NHS organisation you're trying to sell into. You are not in it. Your clinical champion is not in it either. It is the meeting where your product's future gets decided, and the person running it has never heard of you. THE TWO-ROOM PROBLEM ...

Apr 15, 2026 healthtech procurement stakeholders

The Measurement Gap That is Killing Your Pipeline

In the last issue we framed The Prevention Economy. This issue goes deeper for founders and builders, helping you frame why healthcare buyers cannot account for what your product prevents, and what to do about it. The problem no one names There is a structural problem in how healthcare systems ac...

Apr 01, 2026 healthtech founder procurement success metrics

The Prevention Argument Isn't Winning. Here's Why.

The prevention argument, on paper, is won. The evidence is clear: chronic disease is preventable, often reversible if caught early, and exponentially cheaper to address upstream than downstream. The IWBI data I work with shows that built environment interventions alone can reduce cardiovascular...

by Sara Roberts — Mar 15, 2026 health scaling the prevention economy

What it Takes to Scale Past Scrappy

The thing that Series A celebrates, doing everything yourself, is the same thing that prevents Series B from arriving on schedule. I've had some version of this conversation four times in the past month. A founder, eighteen months post-close, working harder than they were pre-close. Revenue movin...

by Sara Roberts — Mar 01, 2026 evolution growth series a series b

When Growth Becomes Fragile

Why post-raise health and longevity ventures stall at the moment they appear strongest, and what to do about it. Most founders expect growth to feel stabilising. Revenue increases. The team expands. Investors lean in. Partnerships get larger. On paper, everything looks stronger. And yet, this i...

Feb 15, 2026 growth healthtech scale series a wellness

The WELL Founder: Why Scaling the Company Isn’t Enough

Over the past few months, I’ve been working quietly on something that feels both overdue and deeply personal. Not a trend piece or the next hot take. A playbook. The WELL Founder Playbook exists for one simple reason; most founders are scaling companies faster than they are scaling themselves. In...

Jan 15, 2026 founder health resilience scaleups wellness

The Founder Identity Gap

I’ve spent more than 15 years scaling ventures across the UK, Europe and Africa in HealthTech, wellbeing, insights-as-a-service and digital transformation. And across all the complexity, regulatory navigation, commercial expansion, clinical integration, enterprise partnerships, one pattern has re...

Jan 06, 2026 company growth entrepreneurship founder identity scaling

Scale Isn’t Speed - It’s Behaviour. Why HealthTech Stalls and What Founders Must Build Next.

Most people assume HealthTech stalls because founders run out of capital, market, or momentum. But after scaling four ventures across three continents, I’ve learned something very different: Companies often stall because of internal behaviours. And that includes the founder. We talk endlessly abo...

by Sara Roberts — Dec 11, 2025 founder growth structure trust

Precision Over Pace: AI’s HealthTech Reality

In 2025, AI became healthcare’s loudest promise and its quietest problem.Billions in investment, breakthrough announcements every quarter, yet one persistent truth remains, AI doesn’t fix systems. It exposes them. Everyone wants to deploy it.Few are ready to sustain it. The Shift: From Speed to ...

Nov 15, 2025 ai ethics leadership operational integrity

The HealthTech Scaling Playbook: How Founders Break the 2–3× Growth Barrier

Most founders don’t fail because their product isn’t good. They fail because they can’t scale what works. The jump from £1 million to £10 million ARR isn’t about doing more, it’s about doing things differently. Systems, discipline, energy and proof begin to matter as much as passion. That’s the ...

Nov 01, 2025 healthtech playbook high growth systems

Equitable Health: Reimagining Access for All

The wealthier you are, the healthier you live. That’s the uncomfortable truth at the heart of modern healthcare. In the UK, the poorest 20% of people hold just 0.5% of total national wealth (ONS, 2025). They’re also three times more likely to experience chronic illness before the age of 50. Meanw...

Oct 15, 2025 equitable health equity healthtech inclusion

Longevity for All: Smarter Systems, Not Just More Signals

Fifteen years ago, one of my first big-stage talks was about data and wisdom. Back then, I argued that we were chasing numbers without asking the bigger question: “What problem are we trying to solve?” Fast forward to today, and healthcare is more quantified than ever. Wearables, blood panels, mi...

Oct 01, 2025 ai data healthtech longevity purpose

1 2

Well Purposed. The commercial case for a healthier world

The fortnightly letter on health systems, economics, and what it actually takes to build and scale in HealthTech - read by 7,500 founders, investors, and operators.

LET'S TALK

DOWNLOAD THE FREE GUIDE